NEFL and supranuclear palsy, progressive, 1: The combination of multiple imaging and neurochemical biomarkers, including PET imaging, MRI, M:P, and CSF NfL levels, significantly improved the accuracy of diagnosis and differentiation of PSP from other neurodegenerative syndromes [102].